跳至主要内容
临床试验/EUCTR2005-002109-22-AT
EUCTR2005-002109-22-AT进行中(未招募)1 期

Comparative Effects of Telmisartan and Candesartan on glucose metabolism in patients with chronic heart failure - Sartans and glucosemetabolism

Medical University of Vienna0 个研究点目标入组 99 人开始时间: 2005年10月27日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
99

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • ·Men and women aged 18 years or older with symptomatic chronic heart failure proven by echocardiography or Tc-Szintigraphy ( EF <45%).
  • ·Hypertension
  • ·normal glucose tolerance Insulin , impaired glucose tolerance (IGT) or type two diabetes, according to the diagnostic criteria of the WHO
  • ·written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • ·systemic cortison treatment
  • ·patients who are on chronic or acute hemodialysis, ultra filtration or peritoneal dialysis
  • ·patients who suffer from infection or malignant disease
  • ·childbearing age or lack of anticonceptive treatment during the study period
  • HBA1c >8.5%
  • on treatment of glitazones

研究者

相似试验